#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA1108920	Binding	Inhibition of human SGLT2 expressed in CHOK1 cells assessed as inhibition of glucose uptake	Homo sapiens	20	ALA1156151	cell-based format	Scientific Literature
2.	ALA1108921	Binding	Inhibition of human SGLT1 expressed in CHOK1 cells assessed as inhibition of glucose uptake	Homo sapiens	20	ALA1156151	cell-based format	Scientific Literature
3.	ALA1108922	Binding	Selectivity ratio of IC50 for human SGLT1 to IC50 for human SGLT2	Homo sapiens	20	ALA1156151	assay format	Scientific Literature
4.	ALA1108923	Functional	Antihyperglycemic activity in Sprague-Dawley rat assessed as inhibition of streptozotocin-induced increase in blood glucose level at 0.3 to 3 mg/kg, po	Rattus norvegicus	5	ALA1156151	organism-based format	Scientific Literature
5.	ALA1108924	ADME	Metabolic stability in human liver microsomes assessed as compound remaining at 5 umol/L after 15 mins by LC/MS/MS analysis	Homo sapiens	6	ALA1156151	microsome format	Scientific Literature
6.	ALA1108925	ADME	Metabolic stability in cryopreserved human hepatocytes assessed as compound remaining at 5 umol/L after 240 mins by LC/MS/MS analysis	Homo sapiens	6	ALA1156151	cell-based format	Scientific Literature
7.	ALA1108928	ADME	Protein binding in human serum at 1 ug/ml	Homo sapiens	5	ALA1156151	cell-free format	Scientific Literature
8.	ALA1109857	Functional	Antihyperglycemic activity in streptozotocin-induced Sprague-Dawley rat assessed as reduction in glucose AUC (0 to 8 hrs) at 0.3 to 3 mg/kg, po	Rattus norvegicus	5	ALA1156151	organism-based format	Scientific Literature